![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » GSK and Vir Biotech Partner on Coronavirus Treatments
GSK and Vir Biotech Partner on Coronavirus Treatments
![Needle.jpg](https://www.fdanews.com/ext/resources/test/Device_Images/Needle.jpg?t=1586293731&width=430)
GSK and Vir Biotech have teamed up to develop a COVID-19 vaccine and they aim to begin a phase 2 trial in the next three to four months.
Vir’s current product development pipeline targets hepatitis B virus, influenza A, SARS-CoV-2, human immunodeficiency virus and tuberculosis.
Upcoming Events
-
18Jul
-
21Oct